AZANTA
Edit

AZANTA

https://www.azanta.com/
Last activity: 14.03.2017
Active
Categories: FinTechHealthTechInfrastructureLogisticsMarketMedTechOwnProductSalesSpecialty
In 2020 Azanta was acquired by Norgine. Azanta was a specialty pharma company focused on women’s health and addiction medicine.
The Company also had a program within oncology. Azanta had its own sales organization supported by in-house medical and regulatory departments and a logistics infrastructure. The Company’s sales force operated in the Nordic countries and in France and worked through partners in other territories. The Company targeted being a market leader within certain specialty pharma product categories, particularlyi n women’s health, employing innovative repositioning and drug formulation strategies.
Following EEP’s investment in 2015, Azanta succeeded a financial turnaround, strengthened its organization and expanded its commercial infrastructure. Also, the Company achieved regulatory approval of Angusta®; a best in class labor inductionmedicine product.
Mentions
1

Investors 2

Mentions in press and media 1

DateTitleDescription
14.03.2017Appointment of new Azanta CEO and market launch of AngustaWolfgang Amann, former Head of Sobi’s commercial operations in the German Speaking European Countries, to Take Helm. Angusta now available for all women requiring induction of labour in the Nordic Countries. Azanta A/S (“Azanta”), a speci...

Reviews 0

Sign up to leave a review

Sign up Log In